Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 50090-7532

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 50090-7532). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatinfigure1 (Atorvastatinfigure1)

FDA Label Image

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)

Atorvastatintabletsfigure1 (Atorvastatintabletsfigure1)
This text provides data on the cumulative incidence of 4.0% for Atorvastatin compared to Placebo. The hazard ratio (HR) between the two treatments is shown as 0.64 with a confidence interval of 0.50-0.83 and a p-value of 0.0005. The observation period for this study ranged from 2.0 to 3.5 years.*
FDA Label Image

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)

Atorvastatintabletsfigure2 (Atorvastatintabletsfigure2)
This text provides information on the cumulative hazard at 15% and 10% for Placebo and Atorvastatin. The hazard ratio (HR) for Atorvastatin is 0.63 with a confidence interval of 0.48-0.83 and a p-value of 0.001. It also presents data on the time to the first primary endpoint through four years of follow-up.*
FDA Label Image

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)

Atorvastatintabletsfigure3 (Atorvastatintabletsfigure3)
This text provides data on the percentage of subjects experiencing events under different doses of Atorvastatin (10 mg and 80 mg). The Hazard Ratio (HR) for the occurrence of events is reported as 0.78 (with 95% confidence interval) with a p-value of 0.0002. Additionally, there is information on the time taken to reach the first major cardiovascular endpoint in years.*
FDA Label Image

Label Image (Lbl500907532)

Label Image (Lbl500907532)
This is information about a product with the code 6485-0 containing Atorvastatin calcium 80 mg in 30 tablets. The tablet is meant for medical use and helps in conditions related to cholesterol.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.